First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside.

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor
April 11, 2024

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents.

Fastenal shares dipped 6.7% to $69.73 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Rallybio Corporation (NASDAQ:RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
  • Rent the Runway, Inc. (NASDAQ:RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.
  • Akanda Corp. (NASDAQ:AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
  • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
  • Candel Therapeutics, Inc. (NASDAQ:CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
  • Enliven Therapeutics, Inc. (NASDAQ:ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
  • Selina Hospitality PLC (NASDAQ:SLNA) rose 21.1% to $0.0923.
  • Globavend Holdings Limited (NASDAQ:GVH) climbed 16.8% to $1.68.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) gained 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 15.3% to $1.9357.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 14.6% to $15.91.
  • AnaptysBio, Inc. (NASDAQ:ANAB) climbed 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
  • Verb Technology Company, Inc. (NASDAQ:VERB) gained 10.4% to $0.2010 after gaining 4% on Wednesday.
  • GigaCloud Technology Inc. (NASDAQ:GCT) rose 10.2% to $34.18.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) gained 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
  • StepStone Group LP (NASDAQ:STEP) rose 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.

Losers

  • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 58% to $1.01 after the company priced its $4.6 million public offering.
  • Enlivex Therapeutics Ltd. (NASDAQ:ENLV) fell 54.5% to $1.81. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.
  • AVITA Medical, Inc. (NASDAQ:RCEL) fell 28.6% to $10.31 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
  • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) fell 19% to $0.3723.
  • Globe Life Inc. (NYSE:GL) fell 14.6% to $89.65.
  • The Lovesac Company (NASDAQ:LOVE) shares fell 14.3% to $20.00 after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
  • Globe Life Inc. (NYSE:GL) fell 13.7% to $90.56.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 12.4% to $1.1601 after jumping around 32% on Wednesday.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 12% to $0.7660 after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • CarMax, Inc. (NYSE:KMX) fell 11.7% to $70.02 after the company reported lower-than-expected fourth-quarter earnings.
  • VBI Vaccines Inc. (NASDAQ:VBIV) dipped 11.3% to $0.5641.
  • Nikola Corporation (NASDAQ:NKLA) fell 11.3% to $0.8680. On April 9, Wolfe Research analyst Scott Group initiated coverage on Nikola with a Peer Perform rating.
  • Marin Software Incorporated (NASDAQ:MRIN) declined 10.8% to $0.5798.
  • SolarBank Corporation (NASDAQ:SUUN) fell 9.3% to $5.29. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) fell 9.1% to $2.29.
  • 9F Inc. (NASDAQ:JFU) fell 8.8% to $2.7046.
  • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.5% to $1.55 after jumping over 50% on Wednesday.
  • ClearOne, Inc. (NASDAQ:CLRO) declined 8.3% to $1.00. The company recently reported fourth-quarter financial results.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 7.3% to $9.83
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 6.2% to $0.8164.
  • Walker & Dunlop, Inc. (NYSE:WD) fell 5.3% to $87.71 after Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $130 to $95.

 

Now Read This: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Continue Reading...

Popular

Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows

Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.

Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions

NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam

A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.

Trump Withdraws Support For 'Wacky' Marjorie Taylor Greene In Sudden, Fiery Split: 'I Can't Take...'

President Donald Trump said he is withdrawing his endorsement of longtime ally Rep. Marjorie Taylor Greene — here's what happened.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns

California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.

UK leader Keir Starmer backs his Treasury chief over claims she misled the public about the economy

LONDON (AP) — British Prime Minister Keir Starmer on Monday defended his Treasury chief against opposition claims that she misled the public and the markets about the state of the public finances before .

The Smart Money Copper Trade - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Donald Trump Nullifies 92% Of Joe Biden's Autopen-Signed Documents: 'Cancelling All Executive Orders And Anything Else'

Trump moved to invalidate what he claims are most of Biden's autopen-signed actions, sparking political backlash and renewed debate over the legality and precedent of using mechanical signatures for presidential documents.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Dogecoin Cheers Debut Of ETF That Aims To Multiply Its Returns: 'Much Congrats'

Dogecoin (CRYPTO: DOGE) cheered the launch of a new exchange-traded fund on Wall Street on Thursday that aims to provide leveraged exposure to the popular meme coin

Scrapyard workers recount horrific scene after UPS plane crash destroyed their Kentucky business

LOUISVILLE, Ky. (AP) — Supervisor Adam Bowman was loading metal onto a truck at a scrapyard just south of the Louisville, Kentucky, airport when he heard what he first thought was a transformer explosion and quickly realized was more horrific.

The Market Just Crossed a Dangerous Line - Ad

The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.

Bill Gates' Daughter Phoebe's AI Shopping Assistant Found Collecting Extensive User Data: Report

Phia, co-founded by Phoebe Gates, has been found collecting extensive user data through its browser extension, raising privacy concerns.

Viking CEO Credits Strong Bookings To Resilient Customer Base Hungry For Travel

Viking Holdings Ltd. (NYSE: VIK) traded higher after beating expectations in third-quarter 2025 results, with strong revenue

Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Canada's prime minister and Alberta's premier sign pipeline deal that could reverse oil tanker ban

TORONTO (AP) — and the premier of Canada’s oil rich province of Alberta agreed Thursday to work toward building a pipeline to the Pacific Coast to diversify the country’s oil exports beyond the United States, in a move that has caused turmoil in Carney's inner circle.

Legally "Skim" $6,361 Into Your Account? - Ad

A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.

MSNBC's name is being replaced, but its leaders insist that its mission will remain the same

NEW YORK (AP) — Asked what viewers should expect when television's MSNBC makes its from NBC News final this weekend, network president Rebecca Kutler points to a poster on the wall of a conference room at its new offices off Times Square.

Billionaire Cari Tuna on why the organization she started will offer free advice to other donors

For San Francisco-based Cari Tuna, the most important decision a philanthropist can make is deciding . Starting Tuesday, the organization she helped found will offer making those choices.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Cipher Mining Stock Pops As JPMorgan Moves To Overweight

Cipher Mining shares are rising Monday after JPMorgan upgraded the stock to Overweight and raised its price target to $18.

Noem Says National Guard Shooting Suspect Was Radicalized In US

DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Tesla Wants To Shift Away From China-Made Components For US Cars: Report

Tesla requires suppliers to exclude Chinese parts for US car production. Despite challenges, aim to switch all parts within 1-2 years.

Dan Ives Calls Nvidia The 'Indisputable Rocky Balboa' Of AI And Gene Munster Agrees As The Jensen Huang-Led Tech Giant Faces Rare November Slump

Despite a rare November stock pullback and rising competition from Google and Broadcom, analysts including Dan Ives and Gene Munster continue to hail Nvidia as the leading force in the AI chip market.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

AP Business News Digest

Here are the AP's top business stories that have moved or are planned to move today. All times U.S. Eastern. For up-to-the minute information on AP's coverage, visit AP Newsroom’s .

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Trump Rolls Back Tariffs On Coffee, Beef And More As Price Debate Heats Up— Here's What You Need To Know

President Donald Trump signed an executive order on Friday that retroactively lowers tariffs on beef, coffee, bananas, and tomatoes, among other agricultural imports.

Nvidia, Palo Alto, Coreweave, Broadcom And AMD: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks advanced on Wednesday as Nvidia's results reignited enthusiasm for AI plays. The Nasdaq climbed 0.59% to 22,564.22.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

What to know about this weekend's G20 summit in South Africa that Trump is boycotting

JOHANNESBURG (AP) — Leaders from the will meet for a summit in this weekend without any U.S. representatives after President Donald Trump announced a boycott over his widely rejected claims that the host country is .

The Smart Money Copper Trade - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

IRS boosts contribution limits for 401(k) retirement plan savers

Americans will be allowed to contribute more of their money to 401(k) and similar retirement saving plans next year.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service